Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive cancer registry aims to improve Real-World treatment insights

NCT ID NCT06877884

Knowledge-focused Sponsor: N-Power Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a large registry that collects information from adult cancer patients during their routine care. Researchers will track treatments, side effects, and outcomes to better understand how cancer is managed in real-world settings. Up to 20,000 participants will be enrolled at participating oncology centers. The goal is to generate high-quality data that can help improve future cancer research and care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could help researchers better understand real-world cancer treatments and outcomes, potentially improving future care.
What could go wrong
This is an observational study, not a treatment trial. It collects data only and does not test any new therapy, so direct patient benefits are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2022

Expected to finish

Jan 2099

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients at oncology sites participating in the registry.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Be a patient at a site (oncology) participating in the Registry Be at least 18 years old Be able and willing to provide signed informed consent Exclusion Criteria: Prisoners/imprisonment at time of screening for eligibility Patients who cannot consent without utilization of a legally authorized representative

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    7 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Bayhealth Cancer Center- Sussex

    RECRUITING

    Milford, Delaware, 19963, United States

    Contact Email: •••••@•••••

  • Bayhealth Cancer Center-Kent

    RECRUITING

    Dover, Delaware, 19901, United States

    Contact Email: •••••@•••••

  • Lankenau Medical Center

    RECRUITING

    Paoli, Pennsylvania, 19301, United States

  • New Mexico Oncology Hematology Consultants

    RECRUITING

    Albuquerque, New Mexico, 87109, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Northwest Oncology & Hematology

    RECRUITING

    Elk Grove Village, Illinois, 60007, United States

    Contact Email: •••••@•••••

  • Oncology Consultants, P.A.

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

  • Pacific Cancer Care

    RECRUITING

    Monterey, California, 93940, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.